Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy

Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma

(2010) Chun-Hung Cho et al.   ANNALS OF HEMATOLOGY

Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia

(2010) Wei Xu et al.   INTERNATIONAL JOURNAL OF CANCER

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

(2010) Andrew S. Artz et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatitis B Virus Reactivation After 23 Months of Rituximab-based Chemotherapy in an HBsAg-negative, Anti-HBs-positive Patient With Follicular Lymphoma

(2010) I-Cheng Lee et al.   Journal of the Chinese Medical Association

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

(2009) Sung-Nan Pei et al.   ANNALS OF HEMATOLOGY

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

(2008) Yi-Fu He et al.   ANNALS OF HEMATOLOGY

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma

(2008) Feng Wang et al.   BMC CANCER

A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma

(2008) Toru Takahashi et al.   Hepatology International

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

(2008) Winnie Yeo et al.   JOURNAL OF CLINICAL ONCOLOGY